Ignite Creation Date:
2025-12-25 @ 2:50 AM
Ignite Modification Date:
2026-03-03 @ 3:59 AM
Study NCT ID:
NCT00811733
Status:
COMPLETED
Last Update Posted:
2017-05-30
First Post:
2008-12-18
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Phase II Trial of Ofatumumab in Subjects With Waldenstrom's Macroglobulinemia
Sponsor:
GlaxoSmithKline
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
110921
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None